High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures.
about
Biomarkers of Alzheimer's diseaseDiagnosis of prostate cancer via nanotechnological approachReverse phase protein microarrays advance to use in clinical trialsCore-shell hydrogel particles harvest, concentrate and preserve labile low abundance biomarkersCandidate proteins, metabolites and transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) clinical studyLogical Analysis of Data (LAD) model for the early diagnosis of acute ischemic stroke.Diverse range of small peptides associated with high-density lipoprotein.Proteomic patterns for cancer diagnosis--promise and challenges.Human body fluid proteome analysis.A robust biomarker discovery pipeline for high-performance mass spectrometry data.A novel peak detection approach with chemical noise removal using short-time FFT for prOTOF MS data.Prediction of outcome of non-small cell lung cancer patients treated with chemotherapy and bortezomib by time-course MALDI-TOF-MS serum peptide profiling.High-throughput and targeted in-depth mass spectrometry-based approaches for biofluid profiling and biomarker discovery.Prostate cancer serum biomarker discovery through proteomic analysis of alpha-2 macroglobulin protein complexes.Blood-based biomarkers of Alzheimer's disease: challenging but feasibleAutomatic selection of preprocessing methods for improving predictions on mass spectrometry protein profilesNanoparticle technology: addressing the fundamental roadblocks to protein biomarker discoverySmart hydrogel particles: biomarker harvesting: one-step affinity purification, size exclusion, and protection against degradationPilot study of the application of magnetic bead protein profiling to the study of biomarkers in addiction research.Soluble plasma HLA peptidome as a potential source for cancer biomarkersPeptidome analysis of cerebrospinal fluid by LC-MALDI MSCapture, enrichment, and mass spectrometric detection of low-molecular-weight biomarkers with nanoporous silicon microparticles.Novel serum biomarkers for detection of excessive alcohol use.Overview and findings from the religious orders studyThe proteomics big challenge for biomarkers and new drug-targets discovery.Plasma and cerebrospinal fluid-based protein biomarkers for motor neuron disease.The heme degradation pathway is a promising serum biomarker source for the early detection of Alzheimer's diseaseDiagnostic potential for urinary proteomics.Proteomics of Alzheimer's disease: understanding mechanisms and seeking biomarkers.Mass spectrometry-based proteomics and peptidomics for biomarker discovery in neurodegenerative diseasesMultiplex biomarkers in blood.Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene'--a new blood biomarker?State of the art in tumor antigen and biomarker discovery.Application of multiple statistical tests to enhance mass spectrometry-based biomarker discoverySerum Proteomic Profiles In Subjects with Heavy Alcohol Abuse.Liquid-phase-based separation systems for depletion, prefractionation and enrichment of proteins in biological fluids for in-depth proteomics analysis.A proteomic workflow for discovery of serum carrier protein-bound biomarker candidates of alcohol abuse using LC-MS/MSProteomic research in psychiatry.Use of proteomic methods in the analysis of human body fluids in Alzheimer research.Blood Biomarkers for Alzheimer's Disease: Much Promise, Cautious Progress.
P2860
Q24650667-868B9845-85E5-4CD1-932D-8384B864FED1Q26777322-EF4BFF3B-72EE-4F46-A5EB-4A93AC6D4D4EQ28384553-A1EDC9D4-D716-4699-A76A-9C69E33A8016Q28474977-53D4A7BB-A5DB-488C-8161-6B04BA7970CAQ28730283-3787EA64-5A91-4F00-90B7-059D420E3D5BQ31162185-650B7359-0AEB-4ED7-8353-0415FBD619D4Q33230587-A92548B5-5E88-47C2-8DA7-122CFE2D54C9Q33252434-F4383B31-344B-4CBE-AC42-1C4DC9CA0786Q33262623-CCAC2870-B7DD-4FDF-8DAC-DCBB3CC1FA0AQ33302448-4AE197FD-C0DC-4406-AE96-6486FE1A778EQ33493472-A06E7A21-1658-4D2B-9ABC-782DF41A4391Q33499899-EF1408BA-8760-409F-96D7-39D8351AB357Q33579375-4B99B666-0C02-4099-8B56-8BD605C33AE1Q33611314-E6410441-5E3A-49C4-9E84-827B3F550099Q33824444-D32F6336-E949-4CBB-827A-93217EC29F87Q33828155-92F5C54C-4903-4B10-A91A-6AA6721D209EQ33862871-C14CA8F8-A3F6-40A5-B813-3869CE95DEBAQ33882805-6F9E0E6A-28A1-4380-B35C-CFFD98452D77Q34015109-28520282-979E-4B21-879E-51D865CB9715Q34279102-3FA66B0A-8DA2-4767-8FA3-9A896097D548Q34374324-6F19E2DC-0DE6-4C2F-86C4-56D548889719Q34489436-C681A417-1E12-4AF4-BD57-B3DAE53326B5Q35143279-F55A4EB6-2AA2-401B-90D4-5104083591FEQ36130996-C247F307-301E-4A12-AAB9-145BC7E790B1Q36432402-4EA345B5-774A-48E4-B4DB-D768938256B2Q36615226-5A41C584-5A49-4DF7-80E6-6FD5AD0252D1Q36660120-4A650BD6-F09F-4CE1-86C7-0BEA2005317BQ36745677-A397D4F3-28A8-45E8-98C9-3F8B2C9132D7Q36787240-4B1BC1A0-FA93-4058-BFD9-876A052D6ED6Q36974613-6BA7132B-84B4-48FF-B2F3-B5BF206E9730Q36998638-0E2D0DC3-9EDD-4760-88B2-9E7FD77FE1ABQ37118083-D2382920-FE0C-41F3-B11D-7B84EB98ADA9Q37132800-2CAEBE63-890A-4017-931E-55B79F1131FBQ37206474-10BCE98F-5FA6-4E64-B6B3-53FCC6DC7626Q37297757-0467DC5C-D49A-49FE-A5CF-AAB83B0E02ADQ37356371-257B3C1C-6CD3-4602-91F3-637AC9F0A696Q37374485-EEBAB4D8-F434-43E9-BF20-2FC080CA2963Q37689362-08C135E0-5033-4ECF-AB5D-E91967907FEFQ38060574-A6CC026B-6FFF-48C2-A684-6BE2C5D42E1CQ38980003-02EB0593-EF08-46CF-B8B2-E5DE63158F03
P2860
High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
High-resolution serum proteomi ...... protein-bound mass signatures.
@ast
High-resolution serum proteomi ...... protein-bound mass signatures.
@en
type
label
High-resolution serum proteomi ...... protein-bound mass signatures.
@ast
High-resolution serum proteomi ...... protein-bound mass signatures.
@en
prefLabel
High-resolution serum proteomi ...... protein-bound mass signatures.
@ast
High-resolution serum proteomi ...... protein-bound mass signatures.
@en
P2093
P1433
P1476
High-resolution serum proteomi ...... protein-bound mass signatures.
@en
P2093
Alvydas Mikulskis
Christopher Lynch
David P Mannion
Eric Denoyer
Eva Golenko
Gershon M Wolfe
Gordon R Whiteley
Guy Della Cioppa
Jeremiah Kelly
John S Rakitan
P304
P356
10.1373/CLINCHEM.2005.053090
P407
P577
2005-08-04T00:00:00Z